Basilea Pharmaceutica Ltd. Logo
 

Oncology 2013

 
 
 

BAL101553

  • ASCO, 2013, A-2566 / A first-in-human (FIH) dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of intravenous BAL101553, a novel microtubule inhibitor, in adult patients with advanced solid tumors. Calvert AH, Gonzalez M, Ganguli S, Ng M, Benafif S, Capelan M, Goldstein R, Shah K, Jarvis C, Flynn M, Forster M, Anderson S, Schmitt-Hoffmann A, Lane H, Engelhardt M, Hannah AL, Tzankov A, Bachmann F, Molife LR, Kristeleit R.

 

 
Info